Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Videos
Filter by Topic
Webinars
2018 AONN+ Midyear Conference
2018 ASCO Insights
AVBCC
AVBCC 2016
Payer-Provider
Personalized Medicine
Pricing
SABCS 2017
EHA 2016
WCLC 2016 - Lung Cancer
View All Videos ›
Importance of Hospital Partnerships for Bispecific Agent Implementation
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
March 21, 2025
Interview with the Innovators
,
Multiple Myeloma
Watch Video
EHR Implementation of Bispecific Agents for Multiple Myeloma
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
March 13, 2025
Interview with the Innovators
,
Multiple Myeloma
,
Bispecific Antibodies
Watch Video
Total Cost of Care for Bispecific Agents in Multiple Myeloma
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
March 10, 2025
Interview with the Innovators
,
Bispecific Antibodies
Watch Video
Clinical Pathways in Multiple Myeloma
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
February 27, 2025
Interview with the Innovators
Watch Video
Payer Policy Development for Bispecific Agents in Multiple Myeloma
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
February 19, 2025
Interview with the Innovators
,
Bispecific Antibodies
Watch Video
REMS Operational Considerations
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
February 11, 2025
Interview with the Innovators
Watch Video
Adopting Bispecific Agents for Multiple Myeloma into Practice
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
February 7, 2025
Interview with the Innovators
Watch Video
Team Education for Bispecific Usage in Multiple Myeloma
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
February 3, 2025
Interview with the Innovators
,
Bispecific Antibodies
Watch Video
Transitions of Care in Multiple Myeloma Patients
FEATURING:
Laura R. Bobolts, PharmD, BCOP
;
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
;
Hakan Kaya, MD
;
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
;
Yonatan Resnick, PharmD
January 27, 2025
Interview with the Innovators
Watch Video
Deciding Between Triplet Therapy for the Treatment of Pancreatic Cancer: NALIRIFOX and FOLFIRINOX
FEATURING:
Tanios S. Bekaii-Saab, MD
;
Shubham Pant, MD
;
Michael Pishvaian, MD, PhD
November 27, 2024
Interview with the Innovators
Watch Video
Deciding Which Patients Are Best Suited for Various First-Line Pancreatic Cancer Treatment Options
FEATURING:
Tanios S. Bekaii-Saab, MD
;
Shubham Pant, MD
;
Michael Pishvaian, MD, PhD
November 21, 2024
Interview with the Innovators
Watch Video
Considerations for Selecting a First-Line Pancreatic Cancer Treatment
FEATURING:
Tanios S. Bekaii-Saab, MD
;
Shubham Pant, MD
;
Michael Pishvaian, MD, PhD
November 14, 2024
Interview with the Innovators
Watch Video
How the Cost of Cancer Treatments May Affect Treatment Decisions for Patients
FEATURING:
Tanios S. Bekaii-Saab, MD
;
Shubham Pant, MD
;
Michael Pishvaian, MD, PhD
November 8, 2024
Interview with the Innovators
Watch Video
Best Practices for Treating Adverse Events Associated With Pancreatic Cancer Therapies
FEATURING:
Tanios S. Bekaii-Saab, MD
;
Shubham Pant, MD
;
Michael Pishvaian, MD, PhD
November 1, 2024
Interview with the Innovators
Watch Video
Key Side Effects That May Occur With First-Line Treatments for Patients With Pancreatic Cancer
FEATURING:
Tanios S. Bekaii-Saab, MD
;
Shubham Pant, MD
;
Michael Pishvaian, MD, PhD
October 24, 2024
Interview with the Innovators
Watch Video
Page 1 of 14
1
2
3
4
Top Trending Articles
1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
3.
AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma